
Velpas S 400mg/100mg Tablet
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Sofosbuvir (400mg) + Velpatasvir (100mg)
Overview Velpas S 400mg/100mg Tablet
HepC Duo 400mg/100mg tablets combine two antiviral agents for managing chronic hepatitis C (HCV). This prescription medication combats the HCV virus, aiming for infection resolution. Adhere strictly to the prescribed dosage and schedule; consumption can be with or without food, but maintain consistent daily timing. Exceeding the recommended dose is unsafe. Disclose any pre-existing conditions, particularly liver or kidney disease, to your physician. Alcohol should be minimized or avoided due to potential adverse interactions. Complete the full course for optimal therapeutic outcomes. Fatigue and cephalalgia are common side effects; adequate hydration and a nutritious diet may mitigate these. Always inform your doctor of any other medications or supplements you are currently using before starting this treatment.
Primary Ingredients of Velpas S 400mg/100mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Velpas S 400mg/100mg Tablet
Managing persistent Hepatitis C virus (HCV) infection
Major Benefits of Velpas S 400mg/100mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Velpas S 400mg/100mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Velpas S 400mg/100mg Tablet:
- Headache
- Tiredness
How to use Velpas S 400mg/100mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Velpas S 400mg/100mg tablets can be consumed with or without food, although consistent timing is recommended.
How Velpas S 400mg/100mg Tablet works:
Sofosbuvir/Velpatasvir 400mg/100mg tablets (Velpas S) combine two antiviral agents to reduce hepatitis C viral load. This dual therapy progressively eliminates the virus from the bloodstream.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Velpas S 400mg/100mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The medication Velpas S 400mg/100mg Tablet is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human subjects, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
Based on current evidence, Velpas S 400mg/100mg tablets appear to pose a negligible risk to nursing infants. Available data from human studies indicate minimal danger to the breastfed child.
DrivingUNSAFE
Driving ability may be impaired by Velpas S 400mg/100mg Tablet, which can induce side effects. Concurrent use of Velpas S 400mg/100mg Tablet with other hepatitis C medications might result in dizziness and blurred vision, potentially impacting driving safety.
KidneyCAUTION
Patients with severe kidney impairment should use Velpas S 400mg/100mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data on Velpas S 400mg/100mg Tablet use in such patients is limited. Dosage alteration is unnecessary for individuals with mild or moderate kidney disease.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely use Velpas S 400mg/100mg tablets without dose modification. Kidney disease, however, should be reported to a physician, as certain patients may require routine liver function testing during treatment.
What if you forget to take Velpas S 400mg/100mg Tablet :
Should you forget a Velpas S 400mg/100mg Tablet dose, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Velpas S 400mg/100mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
